A retired cardiologist and former FDA official documents his personal effort to find a Parkinson's treatment, mixing commentary on recent trial results with his own research history and operational updates on drug development. Readers get a firsthand, detailed view of how a non-specialist approaches PD science and what regulatory and safety steps a potential drug must clear.